Atassi G - Search Results

1

Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.

Léonce S, Pérez V, Lambel S, Peyroulan D, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi G, Hickman JA, Pierré A. Léonce S, et al. Among authors: atassi g. Mol Pharmacol. 2001 Dec;60(6):1383-91. doi: 10.1124/mol.60.6.1383. Mol Pharmacol. 2001. PMID: 11723246

2

Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines.

Pierré A, Léonce S, Pérez V, Atassi G. Pierré A, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1998;42(6):454-60. doi: 10.1007/s002800050845. Cancer Chemother Pharmacol. 1998. PMID: 9788571

3

Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.

Guilbaud N, Kraus-Berthier L, Meyer-Losic F, Malivet V, Chacun C, Jan M, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi G, Hickman J, Pierré A. Guilbaud N, et al. Among authors: atassi g. Clin Cancer Res. 2001 Aug;7(8):2573-80. Clin Cancer Res. 2001. PMID: 11489841

4

Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.

Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G. Léonce S, et al. Among authors: atassi g. Biochem Pharmacol. 1992 Nov 3;44(9):1707-15. doi: 10.1016/0006-2952(92)90063-o. Biochem Pharmacol. 1992. PMID: 1360210

5

Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.

Kraus-Berthier L, Guilbaud N, Léonce S, Parker T, Genissel P, Guillonneau C, Goldstein S, Atassi G, Pierré A. Kraus-Berthier L, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 2002 Aug;50(2):95-103. doi: 10.1007/s00280-002-0481-z. Epub 2002 Jun 25. Cancer Chemother Pharmacol. 2002. PMID: 12172972

6

[In vitro characterization of S9788, a new modulator of multidrug resistance].

Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G. Pérez V, et al. Among authors: atassi g. Bull Cancer. 1993 Apr;80(4):310-25. Bull Cancer. 1993. PMID: 8173185 French.

7

Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.

Pérez V, Pierré A, Léonce S, Anstett M, Atassi G. Pérez V, et al. Among authors: atassi g. Anticancer Res. 1993 Jul-Aug;13(4):985-90. Anticancer Res. 1993. PMID: 8352569

8

In vitro cytotoxicity of S16020-2, a new olivacine derivative.

Léonce S, Perez V, Casabianca-Pignede MR, Anstett M, Bisagni E, Pierré A, Atassi G. Léonce S, et al. Among authors: atassi g. Invest New Drugs. 1996;14(2):169-80. doi: 10.1007/BF00210788. Invest New Drugs. 1996. PMID: 8913838

9

Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.

Elomri A, Skaltsounis AL, Michel S, Tillequin F, Koch M, Rolland Y, Pierré A, Atassi G. Elomri A, et al. Among authors: atassi g. Chem Pharm Bull (Tokyo). 1996 Nov;44(11):2165-8. doi: 10.1248/cpb.44.2165. Chem Pharm Bull (Tokyo). 1996. PMID: 8945782

10

Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo.

Morris AD, Léonce S, Guilbaud N, Tucker GC, Pérez V, Jan M, Cordi AA, Pierré A, Atassi G. Morris AD, et al. Among authors: atassi g. Anticancer Drugs. 1997 Sep;8(8):746-55. doi: 10.1097/00001813-199709000-00003. Anticancer Drugs. 1997. PMID: 9396618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters